(6S,9R,12S,15S,18S)-1-amino-18-((S)-1-((S)-2-((S)-1-((2S,3S)-1-((R)-1-amino-3-mercapto-1-oxopropan-2-ylamino)-3-methyl-1-oxopentan-2-ylamino)-4-carboxy-1-oxobutan-2-ylcarbamoyl)pyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-ylcarbamoyl)-6-((S)-1-((6R,9R,12S,15S)-15-(carboxymethyl)-12-(hydroxymethyl)-6,9-bis(mercaptomethyl)-1,4,7,10,13-pentaoxo-1-phenyl-2,5,8,11,14-pentaazahexadecane)pyrrolidine-2-carboxamido)-12-(3-guanidinopropyl)-15-(4-hydroxybenzyl)-1-imino-9-(mercaptomethyl)-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazaicosan-20-oic acid

ID: ALA4763515

Chembl Id: CHEMBL4763515

PubChem CID: 162659521

Max Phase: Preclinical

Molecular Formula: C80H117N25O25S4

Molecular Weight: 1957.23

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CNC(=O)c1ccccc1)C(=O)N[C@@H](CS)C(N)=O

Standard InChI:  InChI=1S/C80H117N25O25S4/c1-3-39(2)62(76(128)100-52(34-131)63(81)115)103-67(119)46(21-22-59(109)110)94-75(127)57-16-9-25-104(57)77(129)49(28-42-31-86-38-90-42)97-69(121)48(29-60(111)112)96-68(120)47(27-40-17-19-43(107)20-18-40)95-65(117)44(13-7-23-87-79(82)83)92-72(124)54(36-133)101-66(118)45(14-8-24-88-80(84)85)93-74(126)56-15-10-26-105(56)78(130)50(30-61(113)114)98-70(122)51(33-106)99-73(125)55(37-134)102-71(123)53(35-132)91-58(108)32-89-64(116)41-11-5-4-6-12-41/h4-6,11-12,17-20,31,38-39,44-57,62,106-107,131-134H,3,7-10,13-16,21-30,32-37H2,1-2H3,(H2,81,115)(H,86,90)(H,89,116)(H,91,108)(H,92,124)(H,93,126)(H,94,127)(H,95,117)(H,96,120)(H,97,121)(H,98,122)(H,99,125)(H,100,128)(H,101,118)(H,102,123)(H,103,119)(H,109,110)(H,111,112)(H,113,114)(H4,82,83,87)(H4,84,85,88)/t39-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,62-/m0/s1

Standard InChI Key:  FDGOGCVLTKRRTJ-XJWRJTOKSA-N

Alternative Forms

  1. Parent:

    ALA4763515

    ---

Associated Targets(Human)

CHRNA9 Tchem Neuronal acetylcholine receptor; alpha9/alpha10 (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABBR1 Tclin GABA-B receptor (281 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna9 Nicotinic acetylcholine receptor alpha9/alpha10 (68 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna3 Neuronal acetylcholine receptor; alpha3/beta2 (421 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna3 Neuronal acetylcholine receptor; alpha3/beta4 (1368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna2 Neuronal acetylcholine receptor; alpha2/beta4 (223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna2 Neuronal acetylcholine receptor; alpha2/beta2 (198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna4 Neuronal acetylcholine receptor; alpha4/beta2 (3557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chrna7 Neuronal acetylcholine receptor protein alpha-7 subunit (3047 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1b Voltage-gated N-type calcium channel alpha-1B subunit (471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1957.23Molecular Weight (Monoisotopic): 1955.7535AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Cai F,Xu N,Liu Z,Ding R,Yu S,Dong M,Wang S,Shen J,Tae HS,Adams DJ,Zhang X,Dai Q.  (2018)  Targeting of N-Type Calcium Channels via GABA-Receptor Activation by α-Conotoxin Vc1.1 Variants Displaying Improved Analgesic Activity.,  61  (22): [PMID:30358401] [10.1021/acs.jmedchem.8b01343]

Source